A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia

NCT01756118 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Leukemia, Myelocytic, Acute
Chronic Myelogenous Leukemia With Crisis of Blast Cells

Interventions

DRUG: BEZ235

Sponsor

Goethe University